尽管销售额略有下降,但Pfizer在利润和成本控制较强的情况下提高了2025年的收入预测。 Pfizer raises 2025 earnings forecast on stronger profits and cost control, despite slightly lower sales.

尽管总销售额下降,在报告第三季度收成比预期的要强之后,辉瑞公司提高了全年收入预测。 Pfizer raised its full-year earnings forecast after reporting stronger-than-expected third-quarter results, despite a decline in overall sales. 该制药公司由于肿瘤和罕见疾病药物的强劲表现以及对呼吸道治疗的需求增加,超过了收入和利润估计数。 The pharmaceutical company exceeded revenue and profit estimates, driven by strong performance in its oncology and rare disease drugs, as well as increased demand for its respiratory treatments. 最新资料反映出利润和成本管理有所改善,尽管收入比去年同期略有下降。 The update reflects improved profitability and cost management, even as revenue dipped slightly from the same period last year.